Medtronic’s CEO Says, “We’ve Got To Be an ‘And’ Company”
How mission plus performance can lead to sustainable success.
Medtronic: Undervalued But Underperforming - Why Innovation Isn't Enough To Lift The Stock
Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...
Nasdaq14d
3 Reasons to Buy Medtronic Stock Like There's No Tomorrow
Over the past year, Medtronic has secured more than 120 regulatory approvals globally for new products, many of which are just starting to gain commercial adoption. The pipeline suggests a runway ...
Medtronic stock hits 52-week high at $92.69 amid steady growth
Medtronic PLC (BVMF:MDTC34) (MDT), a global leader in medical technology, services, and solutions, has reached a new 52-week high, with its stock price climbing to $92.69. According to InvestingPro ...
Yahoo Finance17d
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
Medtronic (MDT) ended the recent trading session ... the company's expected earnings growth trajectory. The Medical - Products industry currently had an average PEG ratio of 2.15 as of ...
Breaking Update: Matthew Walter Engages In Options Exercise At Medtronic Realizing $23K
What Happened: The latest Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission uncovered Walter, SVP at Medtronic, exercising stock options for 1,337 shares of MDT. The total ...
Medtronic (MDT) Outperforms Broader Market: What You Need to Know
In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.